DA

Dr. Thais Aliabadi

Celebrity OB/GYN and Weight-loss Specialist, Founder of Trimly at Trimly
On the record
Represented by:
Share profile 
Link:
Bio
Edit

Dr. Thaïs Aliabadi is one of the most sought after women's health experts among national and international patients. Based in Beverly Hills, she is fluent in English, French, Farsi & Spanish and has been in private practice since 2002. Board-certified by the American Board of Obstetrics and Gynecology, Dr. Aliabadi’s ability to provide the latest diagnostic & treatment services coupled with her compassion has led to her growing international practice with patients traveling from Europe and the Middle East, including members of the royal family, as well as A-list and reality TV celebrities such as The Kardashians. Dr. Aliabadi’s passion and work led her to create Trimly – a personalized weight-loss treatment that brings effective, lasting change to people who have been struggling with issues, including those whose weight is as a result of Polycystic Ovary Syndrome (PCOS). Her expertise has been featured on “The Doctors,” “Keeping Up With The Kardashians,” “Chasing the Cure,” “The Dr. Phil Show,” Yahoo!, Glamour, Fox News and People Magazine, just to name a few.

Employment
Sign up to view all
  • Trimly
    Celebrity OB/GYN and Weight-loss Specialist, Founder of Trimly
Recent Quotes
Sign up to view all
  • Upwards of 70% of patients with PCOS also have insulin resistance independent of weight. Overweight or obese patients with PCOS and insulin resistance gain weight very easily and have a difficult time losing weight. Insulin resistance also worsens PCOS symptoms by stimulating ovaries to make excess testosterone. Weight loss improves insulin sensitivity, therefore, in addition to diet and exercise, semaglutide can help regulate both PCOS symptoms and weight.

    In women who are dealing with menopause, hormonal changes can cause easy weight gain especially around the waist. Sleep disturbances are common during the menopausal transition, which leaves women feeling more tired during the day. When people are tired, they tend to be less physically active which worsens weight gain. Semaglutide medications can help regulate food intake and promote weight loss.

  • To qualify for a semaglutide, a patient needs to have a Body Mass Index (BMI) of 30 or higher or a BMI of 27 or higher plus a comorbidity and unable to achieve adequate weight loss from diet and exercise. A comorbidity is when a person has more than one medical condition at the same time that puts them at an increased risk for serious health complications. Examples of comorbidities include: Type 2 diabetes, high blood pressure, high cholesterol, sleep apnea and osteoarthritis, to name a few.

  • Ozempic and Wegovy are both semaglutide medications that are approved for people with type 2 diabetes who need better control of their blood sugar levels despite diet and exercise. The main difference is that Wegovy is also approved for weight loss but Ozempic is not.

Headshots
Popularity